| abstract |
Disclosed herein is a composition for the treatment bone fracture comprising N-hydroxy-4-{5- [4- (5-isopropyl-2- methyl-1, 3-thiazol-4-yl)phenoxy] pentoxyl -benzamidine, 4-{5- [4- (5-isopropyl-2-methyl--l, 3-thiazol-4-yl)phenoxy]pentoxy}- benzamidine or pharmaceutically acceptable salts thereof as a medicinally effective ingredient. The composition of the present invention can significantly reduce the volume of bony callus, increase bony density and strength of bony callus, and decrease the contents of connective tissue and cartilage tissue in bony callus, and thus promote loss and ossification of the bony callus formed during the fracture healing process. Therefore, the composition of the present invention is useful for the treatment of bone fracture. |